Compound serving as anti-tumor medicine synergist and reversal agent
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- INST OF ZOOLOGY CHINESE ACAD OF SCI
- Publication Date
- 2018-09-14
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of medicine, and in particular relates to a compound used as a synergist and a reversal agent for antitumor drugs. Background technique
[0002] Cancer is one of the important diseases that endanger public health, and its morbidity and mortality are increasing year by year. Although there are many ways to treat cancer, chemotherapy is still a common method of treatment, but long-term chemotherapy can easily lead to multidrug resistance in patients, resulting in reduced curative effect or even failure of chemotherapy.
[0003] The mechanism of multidrug resistance in tumor cells is quite complex, and there are many influencing factors. Among them, multidrug resistance gene 1 (MDR1) plays a major role in multidrug resistance of tumor cells and is the most deeply studied. It is P-glycoprotein (P-gp), which acts as an efflux pump for macromolecular drugs or poisons that rely on ATP energy, and can expel drugs o...